Skip to main content
OpenTrials

Clinical trial condition

Carcinoma

Explore clinical trials studying Carcinoma. Study availability and eligibility vary by location and protocol.

8,894 public trials 2,121 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma trial results

Active, not recruiting

A Study of LVGN6051 Combination Therapy in Patient With Head and Neck Squamous Cell Carcinoma (HNSCC)

NCT06378177

Conditions
Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +6 more
Locations
  • Anhui Cancer Hospital Hefei, Anhui, China
  • Beijing Cancer Hospital Beijing, Beijing Municipality, China
  • Beijing Tongren Hospital Affiliated to Capital Medical University Beijing, Beijing Municipality, China
  • Fujian cancer hospital Fuzhou, Fujian, China
View all 16 locations
View Trial Details
Active, not recruiting

A Study of Belzutifan (MK-6482) Plus Pembrolizumab (MK-3475) Versus Placebo Plus Pembrolizumab in Participants With Clear Cell Renal Cell Carcinoma Post Nephrectomy (MK-6482-022)

NCT05239728

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
Locations
  • Mayo Clinic in Arizona - Phoenix ( Site 3554) Phoenix, Arizona, United States
  • City of Hope Comprehensive Cancer Center ( Site 3567) Duarte, California, United States
  • Moores Cancer Center-Clinical Trials Office- Genitourinary ( Site 3516) La Jolla, California, United States
  • UCLA Hematology/Oncology - Westwood (Building 200 Suite 140)-Department of Urology/Institute of Uro ( Site 3520) Los Angeles, California, United States
View all 285 locations
View Trial Details
Active, not recruiting

A Study of Radiation Therapy and Cemiplimab for People With Skin Cancer

NCT05574101

Conditions
Carcinoma, Carcinoma, Squamous Cell, Cutaneous Squamous Cell Carcinoma, +14 more
Locations
  • University of Colorado (Data Collection Only) Aurora, Colorado, United States
  • Moffitt Cancer Center (Data Collection Only) Tampa, Florida, United States
  • Memorial Sloan Kettering Cancer Center at Basking Ridge (All Protocol Activities) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (All Protocol Activities) Middletown, New Jersey, United States
View all 13 locations
View Trial Details
Active, not recruiting

Dose Escalation and Dose Expansion Study of RMC-6291 Monotherapy in Subjects With Advanced KRASG12C Mutant Solid Tumors

NCT05462717

Conditions
Adenocarcinoma, Adnexal Diseases, Advanced Solid Tumor, +60 more
Locations
  • Highlands Oncology Group Springdale, Arkansas, United States
  • UC Irvine Cancer Center Orange, California, United States
  • UC Davis Cancer Center Sacramento, California, United States
  • UCSF San Francisco, California, United States
View all 64 locations
View Trial Details
Active, not recruiting

A Study of Belzutifan (MK-6482) Versus Everolimus in Participants With Advanced Renal Cell Carcinoma (MK-6482-005)

NCT04195750

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +13 more
Locations
  • Faculty Office Towers 1132 ( Site 1538) Birmingham, Alabama, United States
  • University of California San Diego Moores Cancer Center ( Site 1546) La Jolla, California, United States
  • St. Joseph Heritage Healthcare Local Lab ( Site 1531) Santa Rosa, California, United States
  • University of Colorado Cancer Center ( Site 1540) Aurora, Colorado, United States
View all 172 locations
View Trial Details
Active, not recruiting

Paediatric Hepatic International Tumour Trial

NCT03017326

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +10 more
Locations
  • St. Anna Kinderspital Vienna, Austria
  • Cliniques Universitaires Saint-Luc Brussels, Woluwe-Saint-Lambert, Belgium
  • University Hospital Motol Prague, Czechia
  • Kuopio University Hospital Kuopio, Finland
View all 32 locations
View Trial Details
Active, not recruiting

Study of Durvalumab Versus Placebo in Combination With Definitive Chemoradiation Therapy in Patient With ESCC

NCT04550260

Conditions
Carcinoma, Carcinoma, Squamous Cell, Digestive System Diseases, +12 more
Locations
  • Research Site Atlanta, Georgia, United States
  • Research Site Louisville, Kentucky, United States
  • Research Site Dallas, Texas, United States
  • Research Site Fairfax, Virginia, United States
View all 133 locations
View Trial Details

Related conditions